Vilya Company

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

Total Funding: 50000000.0
Headquarters: Seattle, Washington, United States
Funding Status: Early Stage Venture
Last Funding Type: Series A
Last Funding Date: 2022-08-29
Investors Number: 1.0
Founded Date: 2022-01-01
Industry: Early Drug Development